Albireo Pharma Investor Relations Material
Latest events
Q3 2022
Albireo Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Albireo Pharma Inc
Access all reports
Albireo Pharma Inc. is a biopharmaceutical company specializing in the development and commercialization of treatments for rare liver diseases, particularly in pediatric and adult populations. The company’s focus is on conditions such as progressive familial intrahepatic cholestasis (PFIC), biliary atresia, and Alagille syndrome.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
ALBO
Country
🇺🇸 United States